Investigation of the possible influence of using blood pressure lowering drugs on plasma free metanephrines concentrations.

Investigation of the possible influence of using blood pressure lowering drugs on plasma free metanephrines concentrations. - Influence of blood pressure lowering drugs on plasma free metanephrines.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38391

Enrollment

Registered

2009-03-19

Start date

2009-02-06

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensie high blood pressure hypertension

Interventions

Blood pression lowering drugs in the normal treatment of hypertension.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Untreated hypertension, periferal oedema, palpitations or migrain.

Exclusion criteria

Exclusion criteria: Treated hypertension. Normal or low blood pressure. If there is no indication to start with -blocker, ACE-inhibitors or diuretics.

Design outcomes

Primary

Measure	Time frame
Free metanephrines (i.e. metanefrine, normetanefrine en 3-methoxytyramine) are measured in plasma.	—

Secondary

Measure	Time frame
Nvt	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)